“p53 signaling pathway”, “HIF-1 signaling pathway”, and “EGFR tyrosine kinase inhibitor resistance” were also enriched, suggesting the potential regulating signaling pathway of non-viral HCC by MDGs (Figure 2C). Here, TP53 is linked to hepatocellular carcinoma.